PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
All information on this page is intended strictly for licensed laboratory research and educational reference
As of now, CagriSema is still in clinical trials and not yet approved for general use
Below is a full breakdown of what separates the two
Elsevier, Oxford, pp 175215 Rausch S, Gouttefangeas C, Hennenlotter J, Laske K, Walter K, Feyerabend S, Chandran PA, Kruck S, Singh-Jasuja H et al (2019) Results of a phase 1/2 study in metastatic renal cell carcinoma patients treated with a patient-specific adjuvant multi-peptide vaccine after resection of metastases
To extend stability, peptide solutions are often stored in sterile buffers with a pH around 56 and kept at -20C or colder when appropriate